Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 901 to 925 of about 5901

Previous 25

Website Changes

05/29/2020

Brain Tumor Webinars!

05/29/2020

Al Musella`s ASCO Highlights Part 2

05/28/2020

A comprehensive survey reveals bacteria are widespread in human tumors and differ by tumor type

05/25/2020

Brain Tumor Awareness Webinars!

05/24/2020

Brain Tumor Webinar Series Continues tonight Sunday 5/24/2020 at 7PM Eastern

05/21/2020

No OS Boost With Opdivo in Recurrent Glioblastoma

05/21/2020

Brain Tumor Webinar Series Continues

05/20/2020

Hoag is First in Nation to Test Innovative Antibody Brain Cancer Drug

05/19/2020

Novel Immunotherapy Approach Holds Promise for Pediatric Brain Cancer

05/17/2020

Musella Foundation Brain Tumor Awareness Month Webinar Series

05/15/2020

Brain Tumor Awareness Monthly Webinar Series video posted: Advances in neuro-imaging

05/15/2020

Musella Foundation Webinar Series: A Promising New Radiotherapy for Recurrent Glioblastoma

05/13/2020

China NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

05/13/2020

Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month

05/09/2020

Brain Tumor Awareness MonthWebinar Series - Advances in neuro-imaging

05/05/2020

Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial

05/05/2020

Diverse Biotech announces orphan-drug designation for treatment of newly diagnosed glioblastoma

05/03/2020

Brain Tumor Awareness Month Seminar Series continues tonight at 7pm eastern time

04/30/2020

Having sold its corporate self, Tocagen auctions off scientific platform to San Diego biotech

04/30/2020

Pharmacokinetics, Safety and Tolerability of Olaparib and Temozolomide for Recurrent Glioblastoma: Results of the Phase I OPARATIC Trial

04/30/2020

UNIQUE GREETING CARDS TAKE ON NEW MEANING IN THE ERA OF COVID-19

04/29/2020

Musella Foundation Webinar Series: This Sunday

04/27/2020

CT103 - Final results for OptimalTTF-1: Optimizing Tumor Treating Fields with targeted skull remodeling surgery for first recurrence glioblastoma: Phase 1 trial

04/27/2020

EF-19 - A post-approval registry study of TTFields for the treatment of recurrent glioblastoma (GBM)

04/27/2020

CBD Shows Promise For Fighting Aggressive Brain Cancer

Our privacy / cookie policy has changed.
Click HERE to read it!